Global Bi-Specific Antibodies Therapy Market Insights and Forecast to 2031

Report ID: 1226317 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Bi-Specific Antibodies Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Fragment-Based Antibodies
        1.2.3 IgG-Based Antibodies
    1.3 Market by Application
        1.3.1 Global Bi-Specific Antibodies Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cancer
        1.3.3 Haemophilia
        1.3.4 Other Non-Cancer Diseases
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Bi-Specific Antibodies Therapy Market Perspective (2017-2028)
    2.2 Bi-Specific Antibodies Therapy Growth Trends by Region
        2.2.1 Bi-Specific Antibodies Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Bi-Specific Antibodies Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Bi-Specific Antibodies Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Bi-Specific Antibodies Therapy Market Dynamics
        2.3.1 Bi-Specific Antibodies Therapy Industry Trends
        2.3.2 Bi-Specific Antibodies Therapy Market Drivers
        2.3.3 Bi-Specific Antibodies Therapy Market Challenges
        2.3.4 Bi-Specific Antibodies Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Bi-Specific Antibodies Therapy Players by Revenue
        3.1.1 Global Top Bi-Specific Antibodies Therapy Players by Revenue (2017-2022)
        3.1.2 Global Bi-Specific Antibodies Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Bi-Specific Antibodies Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Bi-Specific Antibodies Therapy Revenue
    3.4 Global Bi-Specific Antibodies Therapy Market Concentration Ratio
        3.4.1 Global Bi-Specific Antibodies Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Bi-Specific Antibodies Therapy Revenue in 2021
    3.5 Bi-Specific Antibodies Therapy Key Players Head office and Area Served
    3.6 Key Players Bi-Specific Antibodies Therapy Product Solution and Service
    3.7 Date of Enter into Bi-Specific Antibodies Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Bi-Specific Antibodies Therapy Breakdown Data by Type
    4.1 Global Bi-Specific Antibodies Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Bi-Specific Antibodies Therapy Forecasted Market Size by Type (2023-2028)
5 Bi-Specific Antibodies Therapy Breakdown Data by Application
    5.1 Global Bi-Specific Antibodies Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Bi-Specific Antibodies Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Bi-Specific Antibodies Therapy Market Size (2017-2028)
    6.2 North America Bi-Specific Antibodies Therapy Market Size by Type
        6.2.1 North America Bi-Specific Antibodies Therapy Market Size by Type (2017-2022)
        6.2.2 North America Bi-Specific Antibodies Therapy Market Size by Type (2023-2028)
        6.2.3 North America Bi-Specific Antibodies Therapy Market Share by Type (2017-2028)
    6.3 North America Bi-Specific Antibodies Therapy Market Size by Application
        6.3.1 North America Bi-Specific Antibodies Therapy Market Size by Application (2017-2022)
        6.3.2 North America Bi-Specific Antibodies Therapy Market Size by Application (2023-2028)
        6.3.3 North America Bi-Specific Antibodies Therapy Market Share by Application (2017-2028)
    6.4 North America Bi-Specific Antibodies Therapy Market Size by Country
        6.4.1 North America Bi-Specific Antibodies Therapy Market Size by Country (2017-2022)
        6.4.2 North America Bi-Specific Antibodies Therapy Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Bi-Specific Antibodies Therapy Market Size (2017-2028)
    7.2 Europe Bi-Specific Antibodies Therapy Market Size by Type
        7.2.1 Europe Bi-Specific Antibodies Therapy Market Size by Type (2017-2022)
        7.2.2 Europe Bi-Specific Antibodies Therapy Market Size by Type (2023-2028)
        7.2.3 Europe Bi-Specific Antibodies Therapy Market Share by Type (2017-2028)
    7.3 Europe Bi-Specific Antibodies Therapy Market Size by Application
        7.3.1 Europe Bi-Specific Antibodies Therapy Market Size by Application (2017-2022)
        7.3.2 Europe Bi-Specific Antibodies Therapy Market Size by Application (2023-2028)
        7.3.3 Europe Bi-Specific Antibodies Therapy Market Share by Application (2017-2028)
    7.4 Europe Bi-Specific Antibodies Therapy Market Size by Country
        7.4.1 Europe Bi-Specific Antibodies Therapy Market Size by Country (2017-2022)
        7.4.2 Europe Bi-Specific Antibodies Therapy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Bi-Specific Antibodies Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Type
        8.2.1 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Bi-Specific Antibodies Therapy Market Share by Type (2017-2028)
    8.3 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Application
        8.3.1 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Bi-Specific Antibodies Therapy Market Share by Application (2017-2028)
    8.4 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Region
        8.4.1 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Bi-Specific Antibodies Therapy Market Size (2017-2028)
    9.2 Latin America Bi-Specific Antibodies Therapy Market Size by Type
        9.2.1 Latin America Bi-Specific Antibodies Therapy Market Size by Type (2017-2022)
        9.2.2 Latin America Bi-Specific Antibodies Therapy Market Size by Type (2023-2028)
        9.2.3 Latin America Bi-Specific Antibodies Therapy Market Share by Type (2017-2028)
    9.3 Latin America Bi-Specific Antibodies Therapy Market Size by Application
        9.3.1 Latin America Bi-Specific Antibodies Therapy Market Size by Application (2017-2022)
        9.3.2 Latin America Bi-Specific Antibodies Therapy Market Size by Application (2023-2028)
        9.3.3 Latin America Bi-Specific Antibodies Therapy Market Share by Application (2017-2028)
    9.4 Latin America Bi-Specific Antibodies Therapy Market Size by Country
        9.4.1 Latin America Bi-Specific Antibodies Therapy Market Size by Country (2017-2022)
        9.4.2 Latin America Bi-Specific Antibodies Therapy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Bi-Specific Antibodies Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Type
        10.2.1 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Bi-Specific Antibodies Therapy Market Share by Type (2017-2028)
    10.3 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Application
        10.3.1 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Bi-Specific Antibodies Therapy Market Share by Application (2017-2028)
    10.4 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country
        10.4.1 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Bi-Specific Antibodies Therapy Introduction
        11.1.4 Roche Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
        11.1.5 Roche Recent Developments
    11.2 Amgen
        11.2.1 Amgen Company Details
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Bi-Specific Antibodies Therapy Introduction
        11.2.4 Amgen Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
        11.2.5 Amgen Recent Developments
    11.3 Sanofi
        11.3.1 Sanofi Company Details
        11.3.2 Sanofi Business Overview
        11.3.3 Sanofi Bi-Specific Antibodies Therapy Introduction
        11.3.4 Sanofi Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
        11.3.5 Sanofi Recent Developments
    11.4 Pfizer
        11.4.1 Pfizer Company Details
        11.4.2 Pfizer Business Overview
        11.4.3 Pfizer Bi-Specific Antibodies Therapy Introduction
        11.4.4 Pfizer Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
        11.4.5 Pfizer Recent Developments
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Details
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Bi-Specific Antibodies Therapy Introduction
        11.5.4 Johnson & Johnson Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Developments
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Bi-Specific Antibodies Therapy Introduction
        11.6.4 AstraZeneca Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
        11.6.5 AstraZeneca Recent Developments
    11.7 AbbVie
        11.7.1 AbbVie Company Details
        11.7.2 AbbVie Business Overview
        11.7.3 AbbVie Bi-Specific Antibodies Therapy Introduction
        11.7.4 AbbVie Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
        11.7.5 AbbVie Recent Developments
    11.8 Lindis Biotech
        11.8.1 Lindis Biotech Company Details
        11.8.2 Lindis Biotech Business Overview
        11.8.3 Lindis Biotech Bi-Specific Antibodies Therapy Introduction
        11.8.4 Lindis Biotech Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
        11.8.5 Lindis Biotech Recent Developments
    11.9 MacroGenics, Inc
        11.9.1 MacroGenics, Inc Company Details
        11.9.2 MacroGenics, Inc Business Overview
        11.9.3 MacroGenics, Inc Bi-Specific Antibodies Therapy Introduction
        11.9.4 MacroGenics, Inc Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
        11.9.5 MacroGenics, Inc Recent Developments
    11.10 Genmab
        11.10.1 Genmab Company Details
        11.10.2 Genmab Business Overview
        11.10.3 Genmab Bi-Specific Antibodies Therapy Introduction
        11.10.4 Genmab Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
        11.10.5 Genmab Recent Developments
    11.11 Alphamab Co. Ltd
        11.11.1 Alphamab Co. Ltd Company Details
        11.11.2 Alphamab Co. Ltd Business Overview
        11.11.3 Alphamab Co. Ltd Bi-Specific Antibodies Therapy Introduction
        11.11.4 Alphamab Co. Ltd Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
        11.11.5 Alphamab Co. Ltd Recent Developments
    11.12 Akeso, Inc.
        11.12.1 Akeso, Inc. Company Details
        11.12.2 Akeso, Inc. Business Overview
        11.12.3 Akeso, Inc. Bi-Specific Antibodies Therapy Introduction
        11.12.4 Akeso, Inc. Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
        11.12.5 Akeso, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Bi-Specific Antibodies Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Fragment-Based Antibodies
    Table 3. Key Players of IgG-Based Antibodies
    Table 4. Global Bi-Specific Antibodies Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Bi-Specific Antibodies Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Bi-Specific Antibodies Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Bi-Specific Antibodies Therapy Market Share by Region (2017-2022)
    Table 8. Global Bi-Specific Antibodies Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Bi-Specific Antibodies Therapy Market Share by Region (2023-2028)
    Table 10. Bi-Specific Antibodies Therapy Market Trends
    Table 11. Bi-Specific Antibodies Therapy Market Drivers
    Table 12. Bi-Specific Antibodies Therapy Market Challenges
    Table 13. Bi-Specific Antibodies Therapy Market Restraints
    Table 14. Global Bi-Specific Antibodies Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Bi-Specific Antibodies Therapy Revenue Share by Players (2017-2022)
    Table 16. Global Top Bi-Specific Antibodies Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bi-Specific Antibodies Therapy as of 2021)
    Table 17. Ranking of Global Top Bi-Specific Antibodies Therapy Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Bi-Specific Antibodies Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Bi-Specific Antibodies Therapy Product Solution and Service
    Table 21. Date of Enter into Bi-Specific Antibodies Therapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Bi-Specific Antibodies Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Bi-Specific Antibodies Therapy Revenue Market Share by Type (2017-2022)
    Table 25. Global Bi-Specific Antibodies Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Bi-Specific Antibodies Therapy Revenue Market Share by Type (2023-2028)
    Table 27. Global Bi-Specific Antibodies Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Bi-Specific Antibodies Therapy Revenue Share by Application (2017-2022)
    Table 29. Global Bi-Specific Antibodies Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Bi-Specific Antibodies Therapy Revenue Share by Application (2023-2028)
    Table 31. North America Bi-Specific Antibodies Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Bi-Specific Antibodies Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Bi-Specific Antibodies Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Bi-Specific Antibodies Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Bi-Specific Antibodies Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Bi-Specific Antibodies Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Bi-Specific Antibodies Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Bi-Specific Antibodies Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Bi-Specific Antibodies Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Bi-Specific Antibodies Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Bi-Specific Antibodies Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Bi-Specific Antibodies Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Bi-Specific Antibodies Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Bi-Specific Antibodies Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Bi-Specific Antibodies Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Bi-Specific Antibodies Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Bi-Specific Antibodies Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Bi-Specific Antibodies Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Bi-Specific Antibodies Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Bi-Specific Antibodies Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Bi-Specific Antibodies Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Bi-Specific Antibodies Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Bi-Specific Antibodies Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Bi-Specific Antibodies Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Bi-Specific Antibodies Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Bi-Specific Antibodies Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Bi-Specific Antibodies Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Bi-Specific Antibodies Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Bi-Specific Antibodies Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Bi-Specific Antibodies Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Roche Company Details
    Table 62. Roche Business Overview
    Table 63. Roche Bi-Specific Antibodies Therapy Product
    Table 64. Roche Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
    Table 65. Roche Recent Developments
    Table 66. Amgen Company Details
    Table 67. Amgen Business Overview
    Table 68. Amgen Bi-Specific Antibodies Therapy Product
    Table 69. Amgen Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
    Table 70. Amgen Recent Developments
    Table 71. Sanofi Company Details
    Table 72. Sanofi Business Overview
    Table 73. Sanofi Bi-Specific Antibodies Therapy Product
    Table 74. Sanofi Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
    Table 75. Sanofi Recent Developments
    Table 76. Pfizer Company Details
    Table 77. Pfizer Business Overview
    Table 78. Pfizer Bi-Specific Antibodies Therapy Product
    Table 79. Pfizer Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
    Table 80. Pfizer Recent Developments
    Table 81. Johnson & Johnson Company Details
    Table 82. Johnson & Johnson Business Overview
    Table 83. Johnson & Johnson Bi-Specific Antibodies Therapy Product
    Table 84. Johnson & Johnson Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
    Table 85. Johnson & Johnson Recent Developments
    Table 86. AstraZeneca Company Details
    Table 87. AstraZeneca Business Overview
    Table 88. AstraZeneca Bi-Specific Antibodies Therapy Product
    Table 89. AstraZeneca Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
    Table 90. AstraZeneca Recent Developments
    Table 91. AbbVie Company Details
    Table 92. AbbVie Business Overview
    Table 93. AbbVie Bi-Specific Antibodies Therapy Product
    Table 94. AbbVie Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
    Table 95. AbbVie Recent Developments
    Table 96. Lindis Biotech Company Details
    Table 97. Lindis Biotech Business Overview
    Table 98. Lindis Biotech Bi-Specific Antibodies Therapy Product
    Table 99. Lindis Biotech Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
    Table 100. Lindis Biotech Recent Developments
    Table 101. MacroGenics, Inc Company Details
    Table 102. MacroGenics, Inc Business Overview
    Table 103. MacroGenics, Inc Bi-Specific Antibodies Therapy Product
    Table 104. MacroGenics, Inc Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
    Table 105. MacroGenics, Inc Recent Developments
    Table 106. Genmab Company Details
    Table 107. Genmab Business Overview
    Table 108. Genmab Bi-Specific Antibodies Therapy Product
    Table 109. Genmab Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
    Table 110. Genmab Recent Developments
    Table 111. Alphamab Co. Ltd Company Details
    Table 112. Alphamab Co. Ltd Business Overview
    Table 113. Alphamab Co. Ltd Bi-Specific Antibodies Therapy Product
    Table 114. Alphamab Co. Ltd Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
    Table 115. Alphamab Co. Ltd Recent Developments
    Table 116. Akeso, Inc. Company Details
    Table 117. Akeso, Inc. Business Overview
    Table 118. Akeso, Inc. Bi-Specific Antibodies Therapy Product
    Table 119. Akeso, Inc. Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
    Table 120. Akeso, Inc. Recent Developments
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Bi-Specific Antibodies Therapy Market Share by Type: 2021 VS 2028
    Figure 2. Fragment-Based Antibodies Features
    Figure 3. IgG-Based Antibodies Features
    Figure 4. Global Bi-Specific Antibodies Therapy Market Share by Application: 2021 VS 2028
    Figure 5. Cancer Case Studies
    Figure 6. Haemophilia Case Studies
    Figure 7. Other Non-Cancer Diseases Case Studies
    Figure 8. Bi-Specific Antibodies Therapy Report Years Considered
    Figure 9. Global Bi-Specific Antibodies Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Bi-Specific Antibodies Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Bi-Specific Antibodies Therapy Market Share by Region: 2021 VS 2028
    Figure 12. Global Bi-Specific Antibodies Therapy Market Share by Players in 2021
    Figure 13. Global Top Bi-Specific Antibodies Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bi-Specific Antibodies Therapy as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Bi-Specific Antibodies Therapy Revenue in 2021
    Figure 15. North America Bi-Specific Antibodies Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Bi-Specific Antibodies Therapy Market Size Market Share by Type (2017-2028)
    Figure 17. North America Bi-Specific Antibodies Therapy Market Size Market Share by Application (2017-2028)
    Figure 18. North America Bi-Specific Antibodies Therapy Market Size Share by Country (2017-2028)
    Figure 19. United States Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Bi-Specific Antibodies Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Bi-Specific Antibodies Therapy Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Bi-Specific Antibodies Therapy Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Bi-Specific Antibodies Therapy Market Size Share by Country (2017-2028)
    Figure 25. Germany Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Bi-Specific Antibodies Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Bi-Specific Antibodies Therapy Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Bi-Specific Antibodies Therapy Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Bi-Specific Antibodies Therapy Market Size Share by Region (2017-2028)
    Figure 35. China Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Bi-Specific Antibodies Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Bi-Specific Antibodies Therapy Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Bi-Specific Antibodies Therapy Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Bi-Specific Antibodies Therapy Market Size Share by Country (2017-2028)
    Figure 45. Mexico Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Bi-Specific Antibodies Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Bi-Specific Antibodies Therapy Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Bi-Specific Antibodies Therapy Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Bi-Specific Antibodies Therapy Market Size Share by Country (2017-2028)
    Figure 51. Turkey Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Roche Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
    Figure 55. Amgen Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
    Figure 56. Sanofi Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
    Figure 57. Pfizer Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
    Figure 58. Johnson & Johnson Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
    Figure 59. AstraZeneca Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
    Figure 60. AbbVie Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
    Figure 61. Lindis Biotech Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
    Figure 62. MacroGenics, Inc Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
    Figure 63. Genmab Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
    Figure 64. Alphamab Co. Ltd Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
    Figure 65. Akeso, Inc. Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Co. Ltd
Akeso, Inc.
Frequently Asked Questions
Bi-Specific Antibodies Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Bi-Specific Antibodies Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Bi-Specific Antibodies Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dielectric Powders

Dielectric Powders market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

Fintech Lending

Fintech Lending market is segmented by players, region (country), by Type and by Application. Pla ... Read More